相关实验视频

Updated: Feb 25, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

在三阴性乳腺癌中通过mRNA疗法重新编程免疫微环境

Shiv Verma¹, Vaibhav Singh¹, Julie E Lang²

¹Department of Urology, Case Western Reserve University, Cleveland, OH 44016, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44016, USA.

|February 23, 2026

概括

使者RNA (mRNA) 免疫疗法为治疗三阴性乳腺癌 (TNBC) 提供了一个有希望的新途径. 这些个性化治疗旨在增强免疫系统.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

三阴性乳腺癌 (TNBC) 具有攻击性,缺乏向疗法,并且经常转移.
目前的治疗方法,包括免疫检查点抑制剂,由于瘤微环境的挑战,有效性有限.
使者RNA (mRNA) 免疫疗法代表了个性化癌症治疗的新方法.

研究的目的:

审查基于mRNA的免疫疗法在三阴性乳腺癌 (TNBC) 的新兴策略.
突出纳米技术在推进TNBC治疗mRNA输送中的作用.
讨论集成抗原向,免疫细胞工程和TNBC的传递技术的未来潜力.

主要方法:

对TNBC基于mRNA的免疫疗法的当前文献的综述.
分析了三个主要的mRNA策略:个性化疫苗,mRNA工程免疫细胞和mRNA编码的免疫调节器.
检查纳米输送系统在提高mRNA疗法的有效性和安全性方面的作用.

主要成果:

mRNA平台正在开发为个性化疫苗,工程免疫细胞 (CAR-T,TCR-T) 和免疫调节剂.
纳米传递系统对于保护mRNA,改善细胞吸收,向瘤或淋巴组织至关重要.
纳米颗粒的持续优化旨在提高组织特异性,mRNA完整性,并降低毒性.

结论:

基于mRNA的免疫疗法在克服TNBC治疗障碍方面显著有前途.
精确抗原向,免疫细胞工程和先进的传递技术的整合是未来进步的关键.
这些方法为TNBC患者提供了更有效和个性化的治疗策略的潜力.

关键词:

mRNA疗法是一种mRNA疗法.纳米交付纳米交付纳米交付三重阴性乳腺癌是什么瘤微环境是一个微环境.

更多相关视频

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.